Besides there has already been a 30 day endometrial study that was safe. I doubt there would be any significant change for a year long endometrial safety study. I ask myself did the competition in the same category ever have to provide a year long endometrial safety study? Almost seems like the FDA set the company up for failure. The company did what they were lead to believe needed to be done. Then the FDA changes course or is it that there was a different group of folks doing the final determinations verses those giving directions?
For now the bottom line is for a long range endometrial study to be done unless things change.
We do know one thing, as things stand. The product works. The safety is clean on a 30 day endometrial study. I would like to know where is the evidence that suggests a long range endometrial study needs to be done?
1/2 cent Vancouver penny mooching pirates!
Recent TXMD News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 09:00:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:40:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 10:18:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 09:16:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:10:09 PM
- TherapeuticsMD Announces Second Quarter 2024 Financial Results • Business Wire • 08/12/2024 08:05:00 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 06/14/2024 09:00:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:18:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:15:43 PM
- TherapeuticsMD Announces First Quarter 2024 Financial Results • Business Wire • 05/10/2024 08:05:00 PM
- TherapeuticsMD Announces Full Year 2023 Financial Results • Business Wire • 03/29/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/07/2023 09:51:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 04:36:35 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/17/2023 02:28:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 02:27:23 PM
- TherapeuticsMD Announces Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM